Atlas Trials

Stereotactic Ablative Radiation Therapy for Abiraterone-Resistant, Oligoprogressive Metastatic Prostate Cancer

Clinical trial NCT04838899 · RECRUITING

Trial details

NCT number
NCT04838899
Sponsor
Sunnybrook Health Sciences Centre
Status
RECRUITING
Phase
Not Applicable
Study type
INTERVENTIONAL
OligoprogressiveCastration-Resistant Prostate Cancer
Start date
2016-07-16
Primary completion
2025-12-31
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.